![](/img/cover-not-exists.png)
Treatment with the Interleukin-17A-Blocking Antibody Secukinumab Does Not Interfere with the Efficacy of Influenza and Meningococcal Vaccinations in Healthy Subjects: Results of an Open-Label, Parallel-Group, Randomized Single-Center Study
Chioato, A., Noseda, E., Stevens, M., Gaitatzis, N., Kleinschmidt, A., Picaud, H.Volume:
19
Language:
english
Journal:
Clinical and Vaccine Immunology
DOI:
10.1128/cvi.00386-12
Date:
October, 2012
File:
PDF, 659 KB
english, 2012